Astera Labs (ALAB) Expected to Announce Earnings on Tuesday

Astera Labs (NASDAQ:ALAB) will likely be announcing its Q1 2025 earnings results after the market closes on Tuesday, May 6th. Analysts expect Astera Labs to post earnings of $0.28 per share and revenue of $151.55 million for the quarter. Astera Labs has set its Q1 2025 guidance at 0.280-0.290 EPS.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Monday, February 10th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. On average, analysts expect Astera Labs to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $66.24 on Tuesday. Astera Labs has a 1-year low of $36.22 and a 1-year high of $147.39. The company has a 50 day moving average price of $65.88 and a 200 day moving average price of $91.52. The stock has a market capitalization of $10.74 billion and a price-to-earnings ratio of -38.29.

Analysts Set New Price Targets

A number of research firms recently weighed in on ALAB. Barclays lifted their target price on Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a research report on Friday, January 17th. Craig Hallum upped their target price on Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a research note on Tuesday, February 11th. Raymond James assumed coverage on shares of Astera Labs in a research note on Friday, March 14th. They set an “outperform” rating and a $82.00 price target on the stock. Morgan Stanley dropped their price objective on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 28th. Finally, Northland Capmk upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 28th. One analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $109.25.

Insider Transactions at Astera Labs

In other news, CFO Michael Truett Tate sold 34,474 shares of the firm’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $92.07, for a total value of $3,174,021.18. Following the transaction, the chief financial officer now owns 244,242 shares of the company’s stock, valued at approximately $22,487,360.94. This trade represents a 12.37 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel Philip Mazzara sold 7,536 shares of Astera Labs stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $92.07, for a total transaction of $693,839.52. Following the sale, the general counsel now directly owns 241,209 shares of the company’s stock, valued at $22,208,112.63. This represents a 3.03 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 633,990 shares of company stock worth $54,235,012.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.